EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost and effectiveness of differentiated ART service delivery strategies in Zambia: a modelling analysis using routine data

Nkgomeleng A Lekodeba iD, Sydney Rosen iD, Bevis Phiri, Sithabiso D Masuku, Caroline Govathson iD, Aniset Kamanga, Prudence Haimbe, Hilda Shakwelele, Muya Mwansa, Priscilla Lumano-Mulenga, Amy N Huber, Sophie J S Pascoe iD und 2 weitere

Journal of the International AIDS Society · 2025

DOI: 10.1002/jia2.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Nkgomeleng A Lekodeba und 13 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, HIV Infections, Delivery of Health Care, Anti-HIV Agents. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, Gates Foundation, Wits Health Consortium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Differentiated service delivery (DSD) models for antiretroviral treatment (ART) have been scaled up in many settings in sub‐Saharan Africa to improve client‐centred care and increase service delivery efficiency. However, given the multitude of models of care currently available, identifying cost‐effective combinations of DSD models that maximize benefits and minimize costs remains critical for guiding their expansion.

Methods

We developed an Excel‐based mathematical model using retrospective retention and viral suppression data from a national cohort of ART clients (≥15 years) in Zambia between January 2018 and March 2022 stratified by age, sex, setting (urban/rural) and model of ART delivery. Outcomes (viral suppression and retention in care), provider costs and costs to clients were estimated from the cohort and published data. The base case reflects the outcomes observed in 2022 for all DSD models for each population sub‐group. For different combinations of nine DSD models and over 1‐year time horizon from the provider perspective, we evaluated the incremental cost‐effectiveness ratio (ICER) per additional client virally suppressed compared to the 2022 base case. Deterministic sensitivity analyses were conducted on key input parameters.

Results

Among 125 scenarios evaluated, six were on the cost‐effectiveness frontier: (1) 6‐month dispensing (6MMD)‐only; (2) 6MMD and adherence groups (AGs); (3) AGs‐only; (4) fast track refills (FTRs) and AGs; (5) FTRs‐only; and 6) AGs and home ART delivery. 6MMD‐only was cost‐saving compared to the base case, increasing retention by 1.2% (95% CI: 0.7−1.8), viral suppression by 1.6% (95% CI: 1.0−2.7) and reducing client costs by 12.0% (95% CI: 10.8−12.4). The next cost‐effective scenarios, 6MMD + AGs and AGs‐only, cost $245 per additional person virally suppressed, increased viral suppression by 2.8% (95% CI: 2.2−3.3) and 4.0% (95% CI: 3.5−4.0) and increased client costs by 20.1% (95% CI: 9.5−28.1) and 52.3% (95% CI: 29.868.7), respectively. ART cost and laboratory test costs were the most influential parameters on provider costs and the ICERs.

Conclusions

Mathematical modelling using existing data can identify cost‐effective DSD model mixes while ensuring all client sub‐populations are considered. In Zambia, scaling up 6MMD to all eligible clients is likely cost‐saving, with further health gains achievable by targeting sub‐populations with selected DSD models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisHIV InfectionsDelivery of Health CareAnti-HIV AgentsHumansZambiaFemaleMaleAdultRetrospective StudiesYoung AdultMiddle AgedAdolescentModels, Theoretical

Stichwörter der Autor:innen

HIVZambiaantiretroviral treatmentcost‐effectivenessdifferentiated service deliverymathematical modelling

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Clinton Health Access Initiative, Lusaka, Zambia.
  • SCHARR, Sheffield Centre for Health and Related Research, Division of Population Health, School of Medicine and Population Health, University of Sheffield, Sheffield, England.
  • Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Ministry of Health, Lusaka, Zambia.

ORCID-Profile: Nkgomeleng A Lekodeba, Sydney Rosen, Caroline Govathson, Sophie J S Pascoe, Lise Jamieson, Brooke E Nichols

Förderung

  • Bill & Melinda Gates Foundation
  • Gates Foundation
  • Wits Health Consortium
  • Bill and Melinda Gates Foundation

Zitieren

APA

Lekodeba, N. A., Rosen, S., Phiri, B., Masuku, S. D., Govathson, C., Kamanga, A., Haimbe, P., Shakwelele, H., Mwansa, M., Lumano-Mulenga, P., Huber, A. N., Pascoe, S. J. S., Jamieson, L., & Nichols, B. E. (2025). Cost and effectiveness of differentiated ART service delivery strategies in Zambia: a modelling analysis using routine data. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.70003

Vancouver

Lekodeba NA, Rosen S, Phiri B, Masuku SD, Govathson C, Kamanga A, et al. Cost and effectiveness of differentiated ART service delivery strategies in Zambia: a modelling analysis using routine data. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.70003

BibTeX
@article{Lekodeba2025,
  author = {Lekodeba, Nkgomeleng A and Rosen, Sydney and Phiri, Bevis and Masuku, Sithabiso D and Govathson, Caroline and Kamanga, Aniset and Haimbe, Prudence and Shakwelele, Hilda and Mwansa, Muya and Lumano-Mulenga, Priscilla and Huber, Amy N and Pascoe, Sophie J S and Jamieson, Lise and Nichols, Brooke E},
  title = {Cost and effectiveness of differentiated ART service delivery strategies in Zambia: a modelling analysis using routine data},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  doi = {10.1002/jia2.70003}
}
Kostenlos starten →